Re: Pssd and desperate…
u/drwillpowers
r/DrWillPowers2026-03-28T00:28:54Z
Dr Will Powers’ own statements and theorizing
Summary (paraphrased)
Replying to a PSSD sufferer who theorized that TRT injections had depleted his androgens and caused penile shrinkage, Powers lays out the excess model in plain terms: the problem is too many androgens, not too few — but trapped intracellularly as accumulated metabolites, so serum levels can look normal while intracellular levels run extremely high. He argues the common inference (shrinkage implies androgen lack, by analogy with androgen-blocked transgender patients) is backwards. He explains "windows" from androgen injections as a transient improvement in the ratio of clean testosterone to accumulated metabolites, which then worsens as the new testosterone converts into more uncleared metabolites. He adds a case note: a patient who appeared not to fit the theory was re-examined — a missed UGT2B7 defect found on the BAM file — showing low epi-testosterone with high urinary testosterone and shunting toward E3 metabolites. He closes by noting most cases involve UGT2B17 plus transporter problems, and by asking for volunteer (non-patient) data to confirm the pattern generalizes.
Key points (paraphrased)
- Excess model in plain terms: intracellular androgen/metabolite accumulation; serum can read normal.
- Shrinkage does not imply androgen lack — the transgender-patient analogy is, in his view, misleading.
- Windows from androgen shots explained as transient ratio improvement, followed by long-term worsening.
- Case note: missed UGT2B7 defect found on BAM re-review; low epi-T with high urinary T and E3 shunting.
- Call for independent (non-patient) volunteer data to test generalizability.
Why it’s in the corpus
The clearest popular-level statement of the androgen-EXCESS model and the mechanistic account of windows. It also documents his case-review method (VCF-to-BAM re-examination rescuing an apparent exception) and his stated need for independent replication beyond his own patient population.
Context — the post Powers was replying toVerbatim third-party text, shown for context only — not Powers’ statement. Usernames removed.ShowHide
Powers' comment replies to [username removed], the author of the "Pssd and desperate" post (20 years on Zoloft, PSSD after a slow taper), who theorized that his penile shrinkage began when TRT injections shut down his natural production in week two, and asked whether going back on TRT/HCG could reverse it.
(Parent context recovered from the r.genit.al mirror on 2026-10-09; Powers' comment text itself is from John's user-provided export.)
Some fields on this page come from the release’s Markdown edition, which carries text the JSON edition omits.
Related records
- Powers · Reddit commentCurated Powers pick
Re: Had another random pssdpfs thought about the…
u/drwillpowers · r/DrWillPowers
Reply to a community member's glucuronidation-theory thought about sulfation labs. Powers notes the discussed factor interacts with androgen production and ABCC-family transporters (he believes ABCB1 specifically, with the caveat that he read it long ago)…
ABCB1LRP2UGT2B15UGT2B17UGT2B7PRH-13982026-04-01T15:22:34ZPFSPSSDPowers Reddit history - Powers · Reddit post
I think I have figured out at least one specific phenotype of PFS, and it is different from the "allopregnanolone" theory
u/drwillpowers · r/DrWillPowers
Powers' key genetics-first post: he proposed a specific PFS phenotype whose "base, core defect" is defective UGT2B17, disabling testosterone's main glucuronidation exit pathway. Carriers show shockingly low 3α-androstanediol glucuronide and near-zero urinary…
AKR1C1AKR1C2AKR1C3AKR1C4HSD17B2+3DWP-0032026PFSCore corpus - Powers gene claim
UGT2B15; UGT2B7 — defective (minor)
Confidence: direct
Defects in these secondary glucuronidation enzymes can compound the UGT2B17 defect, further reducing testosterone exit capacity.
UGT2B15UGT2B17UGT2B7PGL-UGT2B15-UGT2B7circa May 2026PFSCore corpus
